Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis

BACKGROUND: Inhaled bronchodilators are the first-line therapy for COPD. Indacaterol is a novel addition to existing long-acting bronchodilators. OBJECTIVES: Systematic review of randomized controlled trials (RCT) on efficacy and safety of indacaterol as compared: 1) with placebo at different dosage...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Vincent C. H., Ma, Polly H. X., Hui, David S. C., Tam, Wilson W. S., Tang, Jin Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743831/
https://www.ncbi.nlm.nih.gov/pubmed/23967106
http://dx.doi.org/10.1371/journal.pone.0070784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743831/
https://www.ncbi.nlm.nih.gov/pubmed/23967106
http://dx.doi.org/10.1371/journal.pone.0070784

Ejemplares similares